Q1 2019 Investor Conference Call

Thursday, April 25, 2019
Start at approx. 2:00 p.m. CEST (12:00 noon UTC)

Investor News April 25, 2019

First quarter of 2019:

Bayer: strong operational start to the year

Group sales increase 4.1 percent (Fx & portfolio adj.) to 13.015 billion euros / EBITDA before special items advances by 44.6 percent to 4.188 billion euros / Crop Science posts substantial sales and earnings gains following the acquisition / Pharmaceuticals shows encouraging sales and earnings growth / Consumer Health below the prior-year quarter, full-year outlook confirmed / Net income declines as expected by 36.5 percent to 1.241 billion euros, held back by special items related to the acquisition and restructuring / Core earnings per share increase 13.8 percent to 2.55 euros / Business outlook for 2019 confirmed MORE